Trial · NCT07895654
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | IH80 Duration Per Event (IH80dpe) | 24-hour study period (each crossover period) | Average duration per intermittent hypoxemia event with SpO₂ below 80% for at least 10 seconds (IH80dpe), measured in seconds per event per 24-hour study period. Calculated as total cumulative duration of SpO₂ below 80% events divided by the number of events in the 24-hour period. |
| Secondary | IH80 Frequency | 24-hour study period (each crossover period) | Number of intermittent hypoxemia events with SpO₂ below 80% for at least 10 seconds per 24-hour study period |
| Secondary | IH85 Frequency | 24-hour study period (each crossover period) | Number of intermittent hypoxemia events with SpO₂ below 85% for at least 10 seconds per 24-hour study period |
| Secondary | IH85 Duration Per Event (IH85dpe) | 24-hour study period (each crossover period) | Average duration per intermittent hypoxemia event with SpO₂ below 85% for at least 10 seconds, in seconds per event per 24-hour study period |
| Secondary | IH90 Frequency | 24-hour study period (each crossover period) | Number of intermittent hypoxemia events with SpO₂ below 90% for at least 10 seconds per 24-hour study period |
| Secondary | IH90 Duration Per Event (IH90dpe) | 24-hour study period (each crossover period) | Average duration per intermittent hypoxemia event with SpO₂ below 90% for at least 10 seconds, in seconds per event per 24-hour study period |
| Secondary | Time in Target SpO₂ Range | 24-hour study period (each crossover period) | Proportion of time with SpO₂ within the target range of 91-95% per 24-hour study period |
| Secondary | Bradycardia Frequency | 24-hour study period (each crossover period) | Number of bradycardia episodes (heart rate below 100 bpm for at least 10 seconds) per 24-hour study period |
| Secondary | Fraction of Inspired Oxygen (FiO₂) | 24-hour study period (each crossover period) | Median FiO₂ required to maintain SpO₂ within target range during the 24-hour study period |
| Secondary | Transcutaneous CO₂ (TcCO₂) | 24-hour study period (each crossover period) | Median transcutaneous CO₂ in mmHg during the 24-hour study period |
| Secondary | Nasopharyngeal Pressure (NP Pressure) | 24-hour study period (each crossover period) | Mean nasopharyngeal pressure during the chin strap vs. no-strap period, as a measure of effective CPAP pressure transmission to the airway |
| Secondary | Respiratory Rate | 24-hour study period (each crossover period) | Median respiratory rate in breaths per minute during the 24-hour study period |
| Secondary | Respiratory Support Escalation | 24-hour study period (each crossover period) | Occurrence of respiratory support escalation during the 24-hour study period |
| Secondary | Feeding Intolerance | 24-hour study period (each crossover period) | Occurrence of feeding intolerance during the 24-hour study period, defined as emesis requiring feeding cessation, or abdominal distension requiring NPO status |
| Other | Severe Bradycardia Frequency (Exploratory) | 24-hour study period (each crossover period) | Number of severe bradycardia episodes (heart rate below 80 bpm for at least 10 seconds) per 24-hour study period. High within-subject variance is expected; this outcome will be analyzed as exploratory and descriptive only |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07895654/registered